How much of Regeneron revenue comes from haram?
Regeneron earns its revenue from the following revenue sources:
- Net Product Sales:
Includes a range of prescription medications used to treat eye-related medical conditions, skin cancer, high cholesterol, and cryopyrin-associated periodic syndromes.
Regeneron also offers an antibody cocktail for Covid-19.
Revenue generated through licensing agreements working with other biotechnology companies and the U.S. Department of Health and Human Services.
Accordingly, Practical Islamic Finance finds none of Regeneron’s revenue to come from anything inherently haram.
Does Regeneron rely on interest to operate?
Regeneron reports its Interest Income & Expenses as a net value.
For the Trailing Twelve Months as of March 31, 2021 (Numbers in thousands, U.S. Dollars):
Total Expenses: $5,208,400
Interest Expense: $65,400
Interest Expense / Total Expense: 1.26%
From the aforementioned, Practical Islamic Finance finds interest (riba) used but not relied upon in Regeneron’s operations.
What is Regeneron’s Environmental, Social and Governance (ESG) impact?
Regeneron does not have any notable environmental achievements.
Regeneron has a slightly above average Glassdoor rating of 3.9 out of 5 from over 900 current and previous employees compared to a 3.3 average for all other Glassdoor rated companies.
In 2020, Regeneron initiated annual, mandatory global privacy training for all its employees and contractors to protect the personal data of its patients.
From the aforementioned, Practical Islamic Finance finds Regeneron to have a net positive ESG impact.
From Regeneron’s business, financial and ESG reviews, Practical Islamic Finance rates Regeneron as: